BlackRock’s Talis Biomedical Corporation Common Stock TLIS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,271
| Closed | -$37K | – | 5292 |
|
|
2024
Q2 | $37K | Sell |
4,271
-440
| -9% | -$3.81K | ﹤0.01% | 4864 |
|
|
2024
Q1 | $41.2K | Sell |
4,711
-5,721
| -55% | -$50.1K | ﹤0.01% | 4852 |
|
|
2023
Q4 | $77.7K | Buy |
10,432
+5,506
| +112% | +$41K | ﹤0.01% | 4799 |
|
|
2023
Q3 | $28.4K | Sell |
4,926
-161
| -3% | -$929 | ﹤0.01% | 5025 |
|
|
2023
Q2 | $36.6K | Sell |
5,087
-411
| -7% | -$2.96K | ﹤0.01% | 5033 |
|
|
2023
Q1 | $40.4K | Sell |
5,498
-966
| -15% | -$7.1K | ﹤0.01% | 5073 |
|
|
2022
Q4 | $43.2K | Sell |
6,464
-17
| -0.3% | -$114 | ﹤0.01% | 5177 |
|
|
2022
Q3 | $65K | Sell |
6,481
-357
| -5% | -$3.58K | ﹤0.01% | 5212 |
|
|
2022
Q2 | $84K | Sell |
6,838
-47,895
| -88% | -$588K | ﹤0.01% | 5193 |
|
|
2022
Q1 | $1.16M | Buy |
54,733
+331
| +0.6% | +$7K | ﹤0.01% | 4530 |
|
|
2021
Q4 | $3.27M | Buy |
54,402
+193
| +0.4% | +$11.6K | ﹤0.01% | 4124 |
|
|
2021
Q3 | $5.08M | Buy |
54,209
+389
| +0.7% | +$36.5K | ﹤0.01% | 3894 |
|
|
2021
Q2 | $8.9M | Buy |
53,820
+5,660
| +12% | +$936K | ﹤0.01% | 3616 |
|
|
2021
Q1 | $9.28M | Buy |
+48,160
| New | +$9.28M | ﹤0.01% | 3559 |
|